How to transfer my Wegovy prescription to

If you’ve been considering GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight loss, you might be wondering: Can I actually get these prescribed through telehealth? The short answer is yes—and for most Americans, it’s easier than you might think.

With obesity affecting over 40% of U.S. adults and weight loss medications showing remarkable results, telehealth has emerged as a convenient, legitimate pathway to treatment. But navigating the legal landscape can feel overwhelming, especially with varying state rules and plenty of misinformation online.

This comprehensive guide breaks down exactly how telehealth prescribing works for weight loss medications, what’s legal in your state, and what to expect from the process.

Understanding the Federal Legal Framework

Why GLP-1 Medications Are Different

Here’s the most important thing to understand: Wegovy, Ozempic, and Mounjaro are not controlled substances. This distinction matters enormously for telehealth access.

The federal Ryan Haight Act—which traditionally required an in-person exam before prescribing via telemedicine—only applies to controlled substances like Adderall or painkillers. Since GLP-1 medications fall outside this category, there’s no federal law requiring you to see a doctor in person before getting a prescription through telehealth.

During the COVID-19 pandemic, temporary flexibilities allowed even controlled substances to be prescribed via telehealth. These flexibilities have been extended through December 31, 2025, but crucially, they were never needed for medications like Wegovy in the first place. The bottom line: federal law fully supports telehealth prescribing of weight loss medications.

Current Regulatory Status (December 2025)

The telehealth landscape has stabilized significantly since the pandemic. While the DEA continues to work on permanent rules for controlled substance prescribing, non-controlled medications like GLP-1 agonists remain fully accessible through telemedicine with no expiration date on that access.

What has changed recently is FDA oversight of compounded versions. In May 2025, the FDA effectively banned routine compounding of semaglutide (the active ingredient in Wegovy and Ozempic) for weight loss, declaring the shortage over. This means you should only receive FDA-approved, brand-name versions through legitimate channels—which actually makes telehealth prescribing safer and more standardized.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-Specific Rules: What You Need to Know

While federal law broadly permits telehealth prescribing, state regulations add an additional layer of requirements. The good news? No state outright bans telehealth for weight loss medications. The nuances lie in how that prescribing must happen.

States With Minimal Restrictions

Several states have embraced telehealth fully, requiring no in-person visits for weight loss medication prescribing:

California, Illinois, New York, Pennsylvania, and Washington allow providers to establish a patient relationship entirely through video consultation. In these states, a licensed provider can evaluate you online, review your medical history and current health status, and send a prescription electronically to your pharmacy—all without requiring you to visit an office.

Washington State, in particular, has been a telehealth pioneer with robust patient privacy protections under the My Health My Data Act (2023), which is especially important when dealing with sensitive weight-loss information.

States Requiring Initial In-Person Exams

Some states mandate an initial physical examination before or shortly after beginning telehealth treatment:

Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, and Texas generally require that first visit to happen face-to-face. This doesn’t mean telehealth is unavailable—rather, you’ll need one in-person appointment to establish care, after which follow-ups can occur virtually.

For example, in Georgia, state medical board policy requires an initial in-person exam before prescribing weight-loss medications via telehealth. However, a 2024 law expanded prescriptive authority for nurse practitioners and physician assistants, making it easier to access care once that initial visit is complete.

Texas takes a particularly strict approach, with medical board rules that strongly encourage an in-person evaluation before prescribing weight management drugs. Texas also requires nurse practitioners and physician assistants to work under formal physician agreements, though they can still prescribe GLP-1 medications within those arrangements.

States With Enhanced Clinical Requirements

A few states don’t necessarily require in-person visits but mandate comprehensive clinical protocols:

Florida requires patients receiving obesity medications to have a BMI of 30 or higher (or 27+ with comorbidities) and mandates follow-up visits at least every three months during treatment. While these appointments can be conducted via telehealth, the frequency requirement ensures ongoing medical oversight.

Virginia requires an initial physical examination, laboratory work, and a documented diet and exercise plan before prescribing weight-loss medications. A follow-up visit must occur within 30 days of starting therapy. These requirements can be met through telehealth consultations combined with at-home lab work or local lab visits.

New Jersey has particularly detailed rules: providers must conduct an extensive initial evaluation including medical history, physical exam, laboratory tests, psychological screening, and documentation of informed consent covering all risks and benefits. While comprehensive, these requirements can still be largely satisfied through a thorough telehealth consultation.

Connecticut requires that weight-loss medication prescriptions include behavioral counseling and a structured diet and exercise plan—reflecting a holistic approach to obesity treatment that goes beyond just writing a prescription.

Who Can Prescribe: Understanding Provider Credentials

Physicians (MDs and DOs)

All states allow licensed physicians to prescribe GLP-1 medications via telehealth, provided they hold an active medical license in the state where the patient is physically located during the consultation. This is straightforward and universally accepted.

Nurse Practitioners (NPs)

The landscape for nurse practitioners varies significantly by state, and this matters for telehealth access:

Full Practice Authority States (34 states plus DC as of 2025): In states like Arizona, California, Colorado, Connecticut, Hawaii, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Mexico, New York, Oregon, Rhode Island, Utah, Vermont, Washington, and Wyoming, nurse practitioners can practice independently after meeting experience requirements (typically 2-3 years of supervised practice). This means NPs can evaluate patients, prescribe medications, and manage treatment entirely on their own through telehealth platforms.

Collaborative Practice States: States like Florida, Georgia, Illinois, Pennsylvania, and many others require NPs to maintain a collaborative agreement or supervisory relationship with a physician. This doesn’t prevent telehealth prescribing—it just means the NP works within a practice structure that includes physician oversight. For patients, this is typically invisible; you’ll receive the same quality care through your telehealth visit.

Restricted Practice States: A handful of states maintain tighter restrictions on NP prescribing authority, particularly for certain medication classes. Texas, for example, requires NPs to work under formal physician delegation agreements and previously prohibited NPs from prescribing Schedule II controlled substances (though this was expanded in 2024 for medications like Adderall; GLP-1s were never affected since they’re not controlled).

Physician Assistants (PAs)

Physician assistants can prescribe weight loss medications in all states, but always work under physician supervision or collaboration. The specific arrangement varies—some states allow PAs significant autonomy within their collaborative relationship, while others require more direct oversight. For telehealth purposes, PAs can absolutely prescribe GLP-1 medications when working within their state’s supervisory framework.

What This Means for You

When you consult with a telehealth provider, you might see an MD, DO, NP, or PA depending on the platform and your state. All of these providers are qualified to prescribe weight loss medications when properly licensed and credentialed. Reputable telehealth services like Klarity Health ensure all providers meet state requirements and have appropriate credentials, so you can feel confident in your care regardless of which type of clinician you see.

The Telehealth Prescription Process: What to Expect

Initial Consultation

A legitimate telehealth weight loss consultation should be thorough—not a quick questionnaire followed by an automatic prescription. Here’s what typically happens:

Medical History Review: You’ll complete a detailed questionnaire covering your current medications, allergies, past medical history, previous weight loss attempts, and any contraindications (like family history of thyroid cancer, which would disqualify you from GLP-1 therapy).

Live Video Appointment: Most states require synchronous (real-time) audio-visual consultation to establish a patient-provider relationship. During this 15-30 minute visit, your provider will review your health information, discuss your weight loss goals, calculate your BMI, and assess whether you’re an appropriate candidate.

Clinical Criteria Assessment: To receive a prescription, you generally need:

• BMI ≥30 (obesity), or
• BMI ≥27 with weight-related comorbidities (type 2 diabetes, hypertension, high cholesterol, or sleep apnea)
• No contraindications (pregnancy, personal or family history of medullary thyroid carcinoma, history of pancreatitis, severe gastroparesis)
• Willingness to commit to lifestyle modifications alongside medication

Informed Consent: Your provider should discuss common side effects (nausea, vomiting, diarrhea, constipation), rare but serious risks (pancreatitis, gallbladder problems, potential thyroid tumors), and the importance of combining medication with diet and exercise changes.

Prescription and Medication Delivery

If approved, your provider will send an electronic prescription to your pharmacy of choice. Because GLP-1 medications are expensive brand-name drugs (often $900-1,500/month without insurance), your provider should help you navigate:

Insurance Coverage: Many insurance plans now cover Wegovy specifically for weight loss (though coverage for Ozempic’s off-label use may be denied). Your telehealth provider can submit prior authorization paperwork if needed.

Manufacturer Savings Programs: Novo Nordisk and Eli Lilly offer savings cards that can significantly reduce copays for eligible patients.

Cash Pay Options: If insurance doesn’t cover your medication, some telehealth platforms have negotiated discounted cash pricing, or your provider can prescribe whichever option is most affordable.

The medication itself is typically a monthly supply of pre-filled injection pens. You’ll start at a low dose (to minimize side effects) and gradually increase over several weeks to months until reaching your target dose.

Ongoing Monitoring and Follow-Up

This is where legitimate telehealth services distinguish themselves from ‘prescription mills.’ Weight loss medication requires ongoing medical supervision:

Follow-Up Schedule: Expect appointments at 1 month, then every 2-3 months. Some states (like Florida and Virginia) legally require specific follow-up timelines.

Monitoring Parameters: Your provider should track:

• Weight loss progress
• Side effects and tolerability
• Blood pressure and heart rate
• Periodic lab work (metabolic panel, A1C if diabetic, lipid panel)
• Diet and exercise adherence

Dosage Adjustments: GLP-1 medications follow a titration protocol, gradually increasing your dose every 4 weeks until you reach maintenance levels or maximum tolerated dose.

Long-Term Planning: These aren’t quick-fix medications—treatment typically lasts a year or longer. Your provider should discuss how long you’ll stay on medication and what happens if you decide to stop (weight regain is common, so transition planning matters).

How Klarity Health Approaches Telehealth Weight Loss Treatment

At Klarity Health, we’ve designed our weight management program to meet the highest standards of medical care while making treatment genuinely accessible.

Provider Availability Across States: We maintain a network of licensed physicians and nurse practitioners credentialed in multiple states, so you can access care regardless of where you live. Our providers understand each state’s specific requirements—whether that’s arranging an initial in-person exam in Georgia or ensuring proper follow-up timing in Virginia.

Transparent Pricing: We accept both insurance and cash payment, with clear pricing disclosed upfront. No surprise bills, no hidden fees. If your insurance requires prior authorization, our team handles that paperwork. If you’re paying cash, we’ll discuss all options including manufacturer savings programs before you commit to treatment.

Comprehensive Care Model: Our approach goes beyond just writing a prescription. Every patient receives:

• Thorough initial medical evaluation
• Personalized nutrition and exercise guidance
• Regular check-ins with your provider
• Access to our clinical team between appointments for questions or concerns
• Coordination with your primary care doctor (if desired)

Safety First: We screen carefully for contraindications, start with conservative dosing, and adjust based on your individual response. If at any point we determine medication isn’t appropriate or safe for you, we’ll have that honest conversation—even if it means you don’t continue treatment with us.

Red Flags: Avoiding Illegitimate Telehealth Services

The popularity of weight loss medications has unfortunately attracted some questionable operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions

Red Flag: ‘Get your Ozempic prescription guaranteed!’ or ‘100% approval rate’

Reality: No legitimate provider can guarantee a prescription before evaluating you. Clinical judgment must guide prescribing decisions. If a service promises medication regardless of your medical history, they’re prioritizing profit over patient safety.

No Live Consultation Required

Red Flag: ‘Just fill out a questionnaire—no video call needed’

Reality: Most states require real-time consultation to establish a patient-provider relationship. Asynchronous (questionnaire-only) prescribing may be illegal in your state and definitely falls below standard of care for prescribing powerful medications.

Compounded or ‘Generic’ Semaglutide

Red Flag: Significantly cheaper ‘semaglutide’ that’s not Wegovy or Ozempic brand name

Reality: As of May 2025, the FDA banned most compounding of semaglutide, declaring the shortage over. Compounded versions haven’t undergone the same safety testing and have been linked to adverse events. Stick with FDA-approved products from licensed pharmacies.

No Follow-Up Plan

Red Flag: Get your prescription and that’s it—no scheduled follow-ups or ongoing monitoring

Reality: Weight loss medication requires regular oversight. A provider who prescribes without scheduling follow-up visits isn’t meeting the standard of care and potentially violates state medical board rules.

Unclear Provider Credentials

Red Flag: Can’t find information about who will prescribe your medication or what state they’re licensed in

Reality: Your provider must be licensed in the state where you’re located. If a telehealth service won’t clearly disclose provider credentials or licensure, it’s a major red flag.

Overseas or Unlicensed Pharmacies

Red Flag: Medication ships from outside the U.S. or from an unknown source

Reality: Your prescription should be filled by a licensed U.S. pharmacy. Overseas sources may sell counterfeit or contaminated products.

Comparing Your Options: Telehealth vs. In-Person Care

Neither approach is inherently superior—it depends on your circumstances, preferences, and state regulations. Many patients find telehealth ideal for ongoing management of chronic conditions like obesity, particularly when lifestyle changes and medication management don’t require frequent hands-on physical exams.

Insurance Coverage and Cost Considerations

Insurance Coverage for GLP-1 Weight Loss Medications

Coverage has expanded dramatically in the past two years:

Medicare: Part D plans vary; Wegovy may be covered if you also have cardiovascular disease, but Medicare is legally prohibited from covering weight loss drugs solely for obesity.

Private Insurance: As of 2025, an estimated 40-50% of commercial plans cover Wegovy for weight loss (meeting criteria). Coverage for Ozempic or Mounjaro used off-label is less consistent and often denied.

Medicaid: Varies by state; many state Medicaid programs don’t cover weight loss medications, though this is slowly changing.

Prior Authorization Process

Most insurance requires prior authorization demonstrating:

• Documented BMI ≥30 or ≥27 with comorbidities
• History of previous weight loss attempts (diet, exercise, possibly other medications)
• No contraindications
• Provider documentation of medical necessity

Your telehealth provider should handle this paperwork, but be prepared for potential delays (2-4 weeks) and possible denials requiring appeals.

Cash Pay Pricing

Without insurance, expect:

• Wegovy: ~$1,349/month retail; manufacturer savings cards may reduce this to $0-25/month for eligible commercially-insured patients
• Ozempic: ~$969/month retail; similar savings programs for diabetes (not weight loss) patients
• Mounjaro: ~$1,023/month retail; Lilly offers savings cards

Cash-pay telehealth programs sometimes negotiate better pharmacy pricing—it’s worth asking about all-in program costs.

Frequently Asked Questions

Do I need an in-person visit in my state?

Check the state-specific table earlier in this guide. States like California, New York, and Washington allow fully remote consultations, while Arkansas, Georgia, New Jersey, and several others require an initial in-person exam. Your telehealth provider should inform you of your state’s requirements during signup.

Can my primary care doctor co-manage my care with a telehealth provider?

Absolutely, and we encourage it. Telehealth providers should offer to send visit summaries to your PCP, and coordinated care leads to better outcomes. Some patients use telehealth for weight loss medication management specifically, while their PCP handles other health needs.

What happens if I have side effects?

Contact your telehealth provider immediately. Most platforms offer messaging or phone support between appointments. Common side effects like mild nausea often resolve with slower dose titration. Severe symptoms (persistent vomiting, severe abdominal pain, signs of pancreatitis) require urgent medical attention—your telehealth provider should have clear protocols for such situations.

How long will I need to stay on medication?

Clinical trials show GLP-1 medications work as long as you take them; most people regain weight if they stop. Typical treatment duration is 12-24+ months, with some patients staying on long-term maintenance. Your provider will periodically reassess whether continued treatment is appropriate based on your progress and goals.

Can I switch from in-person care to telehealth (or vice versa)?

Yes. If you’re currently seeing a provider in person, you can transition to telehealth for convenience. Similarly, if telehealth isn’t working for you, you can always switch to traditional care. The key is ensuring continuity—your new provider should obtain medical records from your previous one.

What if I move to another state during treatment?

This can be tricky. Your provider must be licensed in your new state to continue prescribing. Many telehealth platforms have multi-state networks to handle this, but you may need to transition to a different provider within the platform. Plan ahead and notify your telehealth service when relocating.

The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded access:

Federal Legislation: The TREATS Act, reintroduced in October 2025, aims to permanently codify telehealth flexibilities for certain medications (primarily focusing on substance use disorder treatment, but signaling broader Congressional support for telemedicine).

State-Level Progress: Mississippi, Pennsylvania, and several other states are considering bills to grant nurse practitioners full practice authority, which would expand the telehealth provider workforce. Other states are streamlining telehealth regulations to reduce unnecessary barriers.

New Medications: Additional GLP-1 medications and combination therapies are in late-stage development. As more options become available, telehealth will remain a primary access point for these treatments.

Improved Technology: Platforms are integrating continuous glucose monitoring, connected scales, and other remote monitoring tools to enhance care quality and safety—making telehealth potentially superior to traditional in-person care for some patients.

Taking the First Step

If you’re considering weight loss medication and wondering whether telehealth is right for you, here’s your action plan:

1. Verify Your State’s Rules: Use the state-specific table in this guide to understand whether you’ll need an initial in-person visit or can access care entirely remotely.

2. Research Reputable Providers: Look for telehealth platforms that clearly disclose provider credentials, require live video consultations, and have comprehensive follow-up protocols. Check reviews and Better Business Bureau ratings.

3. Check Your Insurance: Contact your insurance company to ask about weight loss medication coverage before your consultation—this will inform your financial planning.

4. Prepare for Your Consultation: Gather information about your medical history, current medications, past weight loss attempts, and health goals. The more thorough your intake information, the more effective your consultation.

5. Ask Questions: During your telehealth visit, don’t hesitate to ask about the provider’s experience with weight loss medications, the follow-up schedule, what happens if you have side effects, and any costs you’ll be responsible for.

Why Choose Klarity Health for Your Weight Loss Journey

Navigating weight loss treatment through telehealth should feel empowering, not confusing. At Klarity Health, we’ve removed the barriers that often prevent people from accessing evidence-based obesity care:

Provider Expertise: Our clinicians specialize in weight management and stay current on the latest research and clinical guidelines for GLP-1 medications.

Flexibility: With appointments available evenings and weekends, and follow-ups that take 15-20 minutes from your home, we fit into your life instead of disrupting it.

Affordability: We accept most major insurance plans and offer competitive cash pricing. You’ll know your costs before committing to treatment—no billing surprises later.

Comprehensive Support: Beyond prescribing, we offer nutrition counseling, lifestyle coaching, and ongoing clinical support to help you achieve sustainable results.

State Compliance: We handle all the complexity of state-specific requirements, so you don’t have to worry about whether your care is legal or appropriate for your location.

Whether you’re just beginning to explore weight loss medications or you’re ready to schedule a consultation, Klarity Health is here to provide expert, accessible, and personalized care. Because quality healthcare shouldn’t require a compromise between convenience and clinical excellence.

Ready to take the next step? Visit Klarity Health to schedule your confidential weight loss consultation with a licensed provider in your state. Most patients get their first appointment within 48 hours—start your journey to healthier weight today.

Citations

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. Available at: https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. COVID-era telehealth prescribing extended – Axios, November 18, 2024. Available at: https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 – McDermott Will & Emery, November 18, 2024. Available at: https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/

4. Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs – Goodwin Procter LLP, March 27, 2024. Available at: https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs

5. Know Your State’s Laws Around Semaglutide – Nextech, April 11, 2025. Available at: https://www.nextech.com/blog/semaglutide-laws-by-state

Research Currency Statement
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid